- Home
- NSIT vs VCYT Comparison
NSIT vs VCYT Comparison
Compare NSIT & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NSIT | VCYT |
|---|---|---|
| Founded | 1988 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 3.0B |
| IPO Year | 1995 | 2013 |
Fundamental Metrics
Financial Performance| Metric | NSIT | VCYT |
|---|---|---|
| Price | $92.31 | $36.37 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | ★ $118.75 | $46.00 |
| AVG Volume (30 Days) | 440.0K | ★ 849.4K |
| Earning Date | 02-05-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.86 | 0.38 |
| Revenue | ★ $8,247,180,000.00 | $495,141,000.00 |
| Revenue This Year | $6.08 | $16.72 |
| Revenue Next Year | $4.31 | $11.31 |
| P/E Ratio | ★ $18.99 | $96.55 |
| Revenue Growth | N/A | ★ 16.41 |
| 52 Week Low | $77.10 | $22.61 |
| 52 Week High | $170.19 | $50.71 |
Technical Indicators
Market Signals| Indicator | NSIT | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 66.10 | 39.61 |
| Support Level | $78.01 | $34.71 |
| Resistance Level | $85.75 | $38.98 |
| Average True Range (ATR) | 3.54 | 1.70 |
| MACD | 1.19 | -0.29 |
| Stochastic Oscillator | 96.36 | 22.92 |
Price Performance
Historical ComparisonAbout NSIT Insight Enterprises Inc.
Insight Enterprises Inc is a Fortune IT provider engaged in helping businesses of all sizes, large enterprises, governments, schools, and healthcare organizations. The company has three geographic operating segments: North America, EMEA, and APAC. It generates maximum revenue from the North America segment. The company provides digital innovation, cloud/data center transformation, connected workforce, and supply chain optimization solutions and services.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.